ACM
Anfield Capital Management Portfolio holdings
AUM
$302M
This Quarter Return
-0.78%
1 Year Return
+14.39%
3 Year Return
+54.96%
5 Year Return
+95.56%
10 Year Return
–
AUM
$321M
AUM Growth
+$321M
(+22%)
Cap. Flow
+$57.1M
Cap. Flow
% of AUM
17.82%
Top 10 Holdings %
Top 10 Hldgs %
57.18%
Holding
275
New
60
Increased
45
Reduced
11
Closed
150
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$11.2M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
$9.29M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$7.2M |
| 4 |
iShares MBS ETF
MBB
|
$3.67M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$3.5M |
Top Sells
Sector Composition
| 1 | Financials | 2.92% |
| 2 | Real Estate | 1.67% |
| 3 | Technology | 1.57% |
| 4 | Consumer Discretionary | 0.29% |
| 5 | Healthcare | 0.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Arcus Biosciences
RCUS
$1.24B
| $275K | 0.09% |
8,041
| – | – |
|
|
TWTR
77
DELISTED
Twitter, Inc.
TWTR
| $243K | 0.08% |
3,699
| – | – |
|
78
TriNet
TNET
$3.46B
| $242K | 0.08% |
+2,499
| New | +$242K |
|
79
Costco
COST
$421B
| $231K | 0.07% |
491
| – | – |
|
80
BlackRock Floating Rate Income Strategies Fund
FRA
$470M
| $228K | 0.07% |
17,078
-16,576
| -49% | -$221K |
|
81
ServiceNow
NOW
$191B
| $213K | 0.07% |
312
| – | – |
|
82
Chipotle Mexican Grill
CMG
$56B
| $208K | 0.06% |
+114
| New | +$208K |
|
83
MSCI
MSCI
$42.7B
| $201K | 0.06% |
322
| – | – |
|
|
FT
84
Franklin Universal Trust
FT
$199M
| $104K | 0.03% |
+12,565
| New | +$104K |
|
|
GUT
85
Gabelli Utility Trust
GUT
$529M
| $99K | 0.03% |
12,426
+1,576
| +15% | +$12.6K |
|
86
BlackRock Income Trust
BKT
$285M
| $94K | 0.03% |
15,295
+2,025
| +15% | +$12.4K |
|
87
Thermo Fisher Scientific
TMO
$183B
| $13K | ﹤0.01% |
+22
| New | +$13K |
|
88
Abbott
ABT
$230B
| $12K | ﹤0.01% |
99
-26
| -21% | -$3.15K |
|
89
Danaher
DHR
$143B
| $12K | ﹤0.01% |
+39
| New | +$12K |
|
90
Edwards Lifesciences
EW
$47.7B
| $12K | ﹤0.01% |
+105
| New | +$12K |
|
91
Intuitive Surgical
ISRG
$158B
| $12K | ﹤0.01% |
+12
| New | +$12K |
|
92
Pfizer
PFE
$141B
| $12K | ﹤0.01% |
+280
| New | +$12K |
|
93
BioNTech
BNTX
$24.1B
| $10K | ﹤0.01% |
+38
| New | +$10K |
|
94
Regeneron Pharmaceuticals
REGN
$59.8B
| $10K | ﹤0.01% |
16
-2
| -11% | -$1.25K |
|
95
Agilent Technologies
A
$35.5B
| $7K | ﹤0.01% |
+46
| New | +$7K |
|
96
Vertex Pharmaceuticals
VRTX
$102B
| $7K | ﹤0.01% |
+40
| New | +$7K |
|
97
West Pharmaceutical
WST
$17.9B
| $5K | ﹤0.01% |
+11
| New | +$5K |
|
98
Labcorp
LH
$22.8B
| $4K | ﹤0.01% |
+15
| New | +$4K |
|
99
Bio-Rad Laboratories Class A
BIO
$7.8B
| $3K | ﹤0.01% |
+4
| New | +$3K |
|
100
Cooper Companies
COO
$13.3B
| $3K | ﹤0.01% |
+7
| New | +$3K |
|